Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: ACTELSAR HCT
Active substances:
Telmisartan+Hydrochlorothiazide
Estonian, English, Latin
ATC code: C09DA85
Dosage form: tablet
Strength: 40mg+12,5mg
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Indication: Treatment of essential hypertension. Actelsar HCT fixed dose combination (40 mg telmisartan/12.5 mg hydrochlorothiazide and 80 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.
Safety features: Yes
Marketing authorization holder: Actavis Group Ptc ehf. 
Marketing authorization number: EU/1/13/817 
Marketing authorization issued on: 15 March 2013 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Description Additional condition
Perearsti õel on õigus välja kirjutada Välja arvatud esmane retsept
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1609859  ACTELSAR HCT  tablet  40mg +12,5mg 28TK  Prescription           
1609860  ACTELSAR HCT  tablet  40mg +12,5mg 30TK  Prescription           
1609871  ACTELSAR HCT  tablet  40mg +12,5mg 56TK  Prescription           
1609882  ACTELSAR HCT  tablet  40mg +12,5mg 84TK  Prescription           
1609893  ACTELSAR HCT  tablet  40mg +12,5mg 90TK  Prescription           
1609905  ACTELSAR HCT  tablet  40mg +12,5mg 98TK  Prescription           
1609916  ACTELSAR HCT  tablet  40mg +12,5mg 250TK  Prescription           
1664401  ACTELSAR HCT  tablet  40mg +12,5mg 14TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription